Braingrade | Peter Schlecht, CEO

Braingrade is developing a neurostimulation solution for patients with Alzheimer's disease that is intended to help them live longer, more independent lives.
Join Our Next Event
Partner with the leaders
shaping the future of
Medtech at LSI USA ‘26
March 16th - 20th, 2026
Waldorf Astoria, Monarch Beach
Speakers
Peter Schlecht
Peter Schlecht
CEO, Braingrade